Press release
Prominent Hydroxychloroquine Market Trend for 2025: Side Effects Of Hydroxychloroquine
Hydroxychloroquine Global Market Report 2025
The hydroxychloroquine industry has seen robust growth in recent times. The market which stood at $2.07 billion in 2024 is predicted to burgeon to $2.22 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The historical growth is linked with increased cases of malaria, growing recognition of hydroxychloroquine, abundant accessibility, and the prevalence of autoimmune diseases.
Expectations are high for the hydroxychloroquine market to significantly expand in the coming years, projecting a surge to $2.86 billion by 2029 with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period is triggered by factors such as the rising demand for combination therapies, larger government funding, an increasing patient populace, better access to healthcare, and a heightened interest in personalised medicine. Notable trends likely to emerge during this forecast period are targeted therapies, the use of telemedicine, drug repurposing, focus on sustainability and environmental impact, global health equity, and advancements in biotechnology.
What Is Driving the Growth Trajectory of the Hydroxychloroquine Market?
The rise in COVID-19 infections has fuelled the need for the hydroxychloroquine market. Hydroxychloroquine's growing demand is due to its employment in treating COVID-19 patients and the continuous clinical trials. The US Food and Drug Administration has permitted the urgent use of hydroxychloroquine for COVID-19 treatment for hospitalized patients or those participating in clinical trials. The World Health Organization's (WHO) COVID-19 Dashboard reveals that as of September 21, 2023, there has been a global reporting of 770,778,396 confirmed COVID-19 cases, leading to 6,958,499 deaths. The countries most severely hit by the virus include the USA, Brazil, Russia, the UK, India, and Spain. Thus, the constant rise in COVID-19 cases worldwide intensifies the need for hydroxychloroquine, resulting in an increase in revenue for the hydroxychloroquine market during the period.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp
Which Leading Companies Are Shaping the Growth of the Hydroxychloroquine Market?
Major companies operating in the hydroxychloroquine market include Bayer AG, Dr. Reddy's Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., McW Healthcare, Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., MAAN Medex, Cinkate Corporation, Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.
What Are the Major Trends Shaping the Hydroxychloroquine Market?
The growth of the hydroxychloroquine market is expected to be curtailed due to associated side effects of its drugs. Use of hydroxychloroquine in treating COVID-19 patients has been linked to severe, even life-threatening, heart rhythm issues. In January 2022, a safety warning about the side effects of this drug when used for COVID-19 treatment outside hospitals or clinical trials was issued by the US Food and Drug Administration. To put it simply, these potential side effects impede the usage of hydroxychloroquine beyond hospital and clinical environments, presenting a challenge to the expansion of the hydroxychloroquine market in the future.
What Are the Key Segments of the Hydroxychloroquine Market?
The hydroxychloroquine market covered in this report is segmented -
1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity
2) By Formulation: Tablets, Injection
3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy
Subsegments:
1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria
2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis
3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus
4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms
5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Which Region Dominates the Hydroxychloroquine Market?
The countries covered in the hydroxychloroquine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Is Covered In The Hydroxychloroquine Global Market Report?
- Market Size Analysis: Analyze the Hydroxychloroquine Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hydroxychloroquine Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hydroxychloroquine Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hydroxychloroquine Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3235
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Hydroxychloroquine Market Trend for 2025: Side Effects Of Hydroxychloroquine here
News-ID: 3932511 • Views: …
More Releases from The Business Research Company
Middle Mile Delivery Market Demonstrates Long-Term Growth Potential At 10% CAGR
The middle mile delivery sector is gaining significant attention as global supply chains evolve and demand for efficient logistics solutions grows. With the rise of e-commerce and technological advancements, this market is set for robust expansion in the coming years. Here's an in-depth overview of the middle mile delivery market size, key players, emerging trends, and segmentation insights shaping its future.
Projected Market Size and Growth Trajectory for Middle Mile Delivery…
Maritime Green Corridor Platform Market Outlook Signals Expansion To $3.53 Billi …
The maritime green corridor platform market is set to experience remarkable expansion in the coming years as the shipping industry intensifies its focus on sustainability and emissions reduction. Driven by global environmental goals and technological advancements, this sector is becoming a crucial part of efforts to decarbonize maritime transport and foster greener trade routes. Below is a detailed overview of the market's anticipated growth, leading companies, emerging trends, and segmentation.
Projected…
Marine Tank Cleaning Services Market Report 2026 Market Outlook Supported By A F …
The marine tank cleaning services sector is poised for notable expansion in the coming years, driven by evolving environmental standards and technological advancements. As the shipping industry continues to prioritize sustainability and operational efficiency, this market is set to experience significant growth backed by several key factors. Here's a detailed overview of its current landscape, influential companies, prevailing trends, and segment breakdowns.
Forecasted Market Value and Growth Trajectory in Marine Tank…
Managed Transportation Services Market Insights Highlight Segment Expansion And …
The managed transportation services industry is on the brink of significant expansion as companies increasingly rely on sophisticated logistics solutions. Advancements in technology, coupled with growing demands for efficiency and sustainability, are setting the stage for rapid market growth through 2030. Let's explore the anticipated market size, key players, current trends, and segments that are shaping this evolving market.
Anticipated Growth Trajectory of the Managed Transportation Services Market
The managed…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
